HLA-DRA anticorps (AA 27-216) (PE)
Aperçu rapide pour HLA-DRA anticorps (AA 27-216) (PE) (ABIN7624289)
Antigène
Voir toutes HLA-DRA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 27-216
-
Fonction
- PE-Linked Anti-HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody
-
Séquence
- Lys27~Glu216
-
Attributs du produit
- The PE-Linked Anti-HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody (Species: Human) has been validated for the following applications: Flow cytometry.
-
Purification
- Affinity Chromatography
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Autre désignation
- HLA-DRA
-
ID gène
- 3122
-
UniProt
- P01903
-
Pathways
- TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Antigène
-